Abdera’s $142 Million Financing

Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...

This content is for Standard 1 Year members only.
Login Join Now